CMOPFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Cosmo Pharmaceuticals N.V.

$98.01-0.77%($-0.76)

TickerSpark Score

41/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMOPF research report →

52-Week Range37% of range

Low $55.00

Current $98.01

High $169.90

Companywww.cosmopharma.com

Cosmo Pharmaceuticals N. V. , a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide.

CEO: Giovanni Di Napoli
IPO: 2017
Employees: 321
HQ: Dublin, IE

Price Chart

+78.20% · this period

Valuation

Market Cap: $1.59B
P/E: -381.00
P/S: 13.38
P/B: 2.85
EV/EBITDA: 190.65
Div Yield: 2.44%

Profitability

Gross Margin: 48.53%
Op Margin: -5.49%
Net Margin: -3.46%
ROE: -0.77%
ROIC: -0.97%

Growth & Income

Revenue: $104.82M · -60.71%
Net Income: $-3,630,478 · -102.72%
EPS: $-0.23 · -102.82%
Op Income: $-10,479,888
FCF YoY: -110.11%

Performance & Tape

52W High: $169.90
52W Low: $55.00
50D MA: $107.77
200D MA: $107.68
Beta: 1.48
Avg Volume: 370

Get TickerSpark's AI analysis on CMOPF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime